As of 2025-09-17, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (45.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.60 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -435.3%.
The range of the Relative Valuation is (43.76) - (47.68) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 15.2x - 18.7x | 17.8x |
| Forward P/E multiples | 17.2x - 19.4x | 18.0x |
| Fair Price | (43.76) - (47.68) | (45.61) |
| Upside | -421.8% - -450.6% | -435.3% |
| Date | P/E |
| 2025-09-16 | -5.35 |
| 2025-09-15 | -5.27 |
| 2025-09-12 | -5.25 |
| 2025-09-11 | -5.24 |
| 2025-09-10 | -5.33 |
| 2025-09-09 | -5.58 |
| 2025-09-08 | -5.36 |
| 2025-09-05 | -5.51 |
| 2025-09-04 | -4.67 |
| 2025-09-03 | -4.72 |
| 2025-09-02 | -4.61 |
| 2025-08-29 | -4.55 |
| 2025-08-28 | -4.56 |
| 2025-08-27 | -4.65 |
| 2025-08-26 | -4.73 |
| 2025-08-25 | -4.56 |
| 2025-08-22 | -4.65 |
| 2025-08-21 | -4.56 |
| 2025-08-20 | -4.52 |
| 2025-08-19 | -4.34 |
| 2025-08-18 | -4.45 |
| 2025-08-15 | -4.36 |
| 2025-08-14 | -4.26 |
| 2025-08-13 | -4.33 |
| 2025-08-12 | -4.23 |
| 2025-08-11 | -4.04 |
| 2025-08-08 | -4.02 |
| 2025-08-07 | -3.96 |
| 2025-08-06 | -4.16 |
| 2025-08-05 | -4.28 |
| 2025-08-04 | -3.95 |
| 2025-08-01 | -3.82 |
| 2025-07-31 | -3.86 |
| 2025-07-30 | -3.87 |
| 2025-07-29 | -3.87 |
| 2025-07-28 | -3.94 |
| 2025-07-25 | -4.12 |
| 2025-07-24 | -4.12 |
| 2025-07-23 | -4.21 |
| 2025-07-22 | -4.11 |
| 2025-07-21 | -4.14 |
| 2025-07-18 | -4.10 |
| 2025-07-17 | -4.05 |
| 2025-07-16 | -3.95 |
| 2025-07-15 | -3.87 |
| 2025-07-14 | -4.00 |
| 2025-07-11 | -4.07 |
| 2025-07-10 | -4.35 |
| 2025-07-09 | -4.31 |
| 2025-07-08 | -3.91 |